125 related articles for article (PubMed ID: 3241626)
1. Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound.
Gros C; Giros B; Schwartz JC; Vlaiculescu A; Costentin J; Lecomte JM
Neuropeptides; 1988 Oct; 12(3):111-8. PubMed ID: 3241626
[TBL] [Abstract][Full Text] [Related]
2. Changes in levels of the tripeptide Tyr-Gly-Gly as an index of enkephalin release in the spinal cord: effects of noxious stimuli and parenterally-active peptidase inhibitors.
Llorens-Cortes C; Gros C; Schwartz JC; Clot AM; Le Bars D
Peptides; 1989; 10(3):609-14. PubMed ID: 2780419
[TBL] [Abstract][Full Text] [Related]
3. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
4. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
9. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats.
Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H
Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639
[TBL] [Abstract][Full Text] [Related]
11. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
12. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
Roques BP
J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
[TBL] [Abstract][Full Text] [Related]
13. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
[TBL] [Abstract][Full Text] [Related]
14. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
Shimamura M; Kawamuki K; Hazato T
J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of enkephalin-degrading enzymes. III: 4-Carboxymethylamino-4-oxo-3 (phenylamino) butanoic acids as enkephalinase inhibitors.
Patel A; Smith HJ; Sewell RD
J Enzyme Inhib; 1991; 5(2):133-49. PubMed ID: 1669442
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
Hazato T; Kase R; Ueda H; Takagi H; Katayama T
Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
[TBL] [Abstract][Full Text] [Related]
18. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
Altstein M; Bachar E; Vogel Z; Blumberg S
Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
[TBL] [Abstract][Full Text] [Related]
19. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
[TBL] [Abstract][Full Text] [Related]
20. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes.
Gros C; Giros B; Schwartz JC
Biochemistry; 1985 Apr; 24(9):2179-85. PubMed ID: 2859885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
